White House Strikes Deal with Pfizer for Lower Drug Prices, Online DTC Website drugtopics.com/view/white-hou…

FDA Approves Roflumilast (Zoryve) Cream 0.05% for Atopic Dermatitis in Children Aged 2-5 Years hcplive.com/view/fda-appro…

Giredestrant/Everolimus Extends PFS for ER+, HER2- Advanced Breast Cancer onclive.com/view/giredestr… #ESMO25

TUB-040 Yields High Response Rare Across Dose Levels for Platinum-Resistant High-Grade Serous Ovarian Cancer onclive.com/view/tub-040-y… #ESMO25

Alectinib achieved a 4-year overall survival rate of 98.4% in resected, ALK-positive, early-stage NSCLC, surpassing chemotherapy outcomes onclive.com/view/adjuvant-… #esmo25

MJH Life Sciences Acquires BPD Healthcare, Expands Reach Among Health Systems and Innovators pharmexec.com/view/mjh-life-…

FDA Approves Revumenib for Relapsed/Refractory NPM1-Mutant Acute Myeloid Leukemia onclive.com/view/fda-appro…

BioRationality: The FDA Sets Sights on Removing Clinical Efficacy Studies for Biosimilars centerforbiosimilars.com/view/bioration…

Investigative Amylin Agonist Eloralintide Proves Superiority to Placebo in Weight Management hcplive.com/view/investiga…

FDA Awards Accelerated Approval to Sibeprenlimab in IgA Nephropathy hcplive.com/view/fda-award…

Odronextamab Plus CHOP Produces Deep, Potentially Durable Responses in Previously Untreated DLBCL onclive.com/view/odronexta… #ASH25

FasTCAR Manufactured BCMAxCD19 CAR T-cell Therapy Shows Promise for Multiple Myeloma cgtlive.com/view/fastcar-m… #ASH25

Rusfertide Maintains Hematocrit Control Through 52 Weeks in VERIFY Study hcplive.com/view/rusfertid… #ash25

Revumenib Plus Decitabine/Cedazuridine and Venetoclax Proves Efficacious in Newly Diagnosed AML onclive.com/view/revumenib… #ASH25

FDA Approves Omidubicel-onlv (Omisirge) As First Cellular Severe Aplastic Anemia Therapy hcplive.com/view/fda-appro…

Giredestrant Improves iDFS Compared With Endocrine Therapy in ER+, HER2– Breast Cancer onclive.com/view/giredestr… #SABCS25

Multimodal AI Model Prognostic for Long-Term Recurrence Following Treatment for Early Breast Cancer onclive.com/view/multimoda… #SABCS25

TERN-701 Elicits Deep Responses in Heavily Pretreated CP-CML onclive.com/view/tern-701-… #ASH25

FDA Approves Semaglutide (Wegovy) Pill As First Oral GLP-1 for Weight Loss hcplive.com/view/fda-appro…

Genentech Reports Positive Results from Phase 2 Trial of CT-388 in Obesity hcplive.com/view/genentech…